Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Clinical and Epidemiologic Research January 2025

Validating Rules for Defining No Improvement of Visual Acuity in Childhood Amblyopia

PDF

Rui Wu; Ruth E. Manny; Jonathan M. Holmes; B. Michele Melia; Zhuokai Li; David K. Wallace; Eileen E. Birch; Raymond T. Kraker; Susan A. Cotter; on behalf of the Pediatric Eye Disease Investigator Group
TAGS: amblyopia, amblyopia, pediatric, visual acuity, false-negative results, false-positive results, visual analogue pain scale, eyeglasses, sensitivity analysis
Invest. Ophthalmol. Vis. Sci.. 2025; 66(1):4. https://doi.org/10.1167/iovs.66.1.4

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Complications of Botulinum Toxin-A for Treatment of Esotropia in Children

Stephen P Christiansen; Danielle Chandler; Katherine A Lee; Rosanne Superstein; Alejandra G De Alba Campomanes; Erick D, Bothun; David K Wallace; Raymond T Kraker; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1333.

ARVO Annual Meeting Abstract June 2015

The Clinical Profile of Moderate Hyperopia in Children Three to Five Years of Age

Donny W Suh; Marjean T Kulp; Trevano W Dean; Raymond T Kraker; Sergul Ayse Erzurum; David K Wallace; Yi Pang; Caroline J Shea; John M Avallone; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2207.

ARVO Annual Meeting Abstract April 2014

Pediatric Cataract Surgery: Baseline Characteristics of a North American Pediatric Eye Disease Registry

Michael Repka; Trevano Dean; Elizabeth Lazar; Sharon Freedman; Denise Hug; Phoebe Lenhart; Bahram Rahmani; Serena Wang; Kimberly G Yen; Ramond T Kraker; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1564.

ARVO Annual Meeting Abstract April 2014

Effect of Patching Versus Observation on Intermittent Exotropia-Specific Health-Related Quality of Life in Children and their Parents

Jonathan M Holmes; David A Leske; Danielle L Chandler; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4545.

OSA Fall Vision Meeting Abstract October 2013

Lessons learned from the Amblyopia Treatment Studies

Susan A. Cotter; for the Pediatric Eye Disease Investigator Group

Journal of Vision. 2013; 13(15):T33. https://doi.org/10.1167/13.15.33

ARVO Annual Meeting Abstract June 2013

Time Course and Predictors of Amblyopia Improvement with 2 Hours of Daily Patching

David Wallace; Elizabeth Lazar; Darren Hoover; Susanna Tamkins; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3990.

ARVO Annual Meeting Abstract March 2012

Evaluation of the Intermittent Exotropia Questionnaire (IXTQ) using Rasch Analysis

David A. Leske; Jonathan M. Holmes; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5450.

Clinical Trials April 2011

Progressive-Addition Lenses versus Single-Vision Lenses for Slowing Progression of Myopia in Children with High Accommodative Lag and Near Esophoria

PDF

Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group
TAGS: child, esophoria, lens (device), lens, crystalline, myopia, vision, papillon-lefevre disease, pediatric advanced life support
Invest. Ophthalmol. Vis. Sci.. 2011; 52(5):2749-2757. https://doi.org/10.1167/iovs.10-6631

ARVO Annual Meeting Abstract April 2011

Optical Treatment of Strabismic and Combined Strabismic-Anisometropic Amblyopia

Susan A. Cotter; Jonathan M. Holmes; Nicole Foster; Michele Melia; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6338.

ARVO Annual Meeting Abstract April 2010

Response to Amblyopia Therapy Depends on Child's Age

J. M. Holmes; E. Lazar; M. Melia; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4757.

ARVO Annual Meeting Abstract April 2009

How Does One Define Success in Amblyopia Treatment?

G. E. Quinn; B. M. Melia; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4697.

ARVO Annual Meeting Abstract April 2009

Treatment of Severe Amblyopia With Atropine: Results From Two Randomized Clinical Trials

M. X. Repka; R. T. Kraker; R. W. Beck; E. Birch; S. A. Cotter; J. M. Holmes; R. W. Hertle; D. L. Hoover; D. L. Klimek; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4753.

ARVO Annual Meeting Abstract May 2008

Defining Stability and Instability in Esotropia

J. M. Holmes; M. Melia; D. L. Chandler; S. P. Christansen; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1804.

ARVO Annual Meeting Abstract May 2008

Left Eye Predominance in Amblyopia

M. X. Repka; R. T. Kraker; K. A. Simons; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2589.

ARVO Annual Meeting Abstract May 2008

Prevalence of Astigmatism in Infants and Young Children: The Multi-Ethnic Pediatric Eye Disease Study

S. A. Cotter; J. Lin; K. Tarczy-Hornoch; M. Borchert; M. Torres; S. Azen; R. Varma; Multi-ethnic Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3136.

ARVO Annual Meeting Abstract May 2007

Treatment of Bilateral Refractive Amblyopia in Children 3-9 Years Old

D. K. Wallace; D. L. Chandler; R. W. Beck; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1109.

ARVO Annual Meeting Abstract May 2006

Treatment of Amblyopia With Refractive Correction Alone

D.K. Wallace; S.A. Cotter; A.R. Edwards; R.W. Beck; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4310.

ARVO Annual Meeting Abstract May 2005

A New Symptom Survey and Quality of Life Questionnaire for Nasolacrimal Duct Obstruction

D.A. Leske; J.M. Holmes; S.R. Cole; E.A. Bradley; D.I. Silbert; M.X. Repka; D.L. Chandler; R.W. Beck; Pediatric Eye Disease Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1913.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Validating Rules for Defining No Improvement of Visual Acuity in Childhood Amblyopia

Complications of Botulinum Toxin-A for Treatment of Esotropia in Children

The Clinical Profile of Moderate Hyperopia in Children Three to Five Years of Age

Pediatric Cataract Surgery: Baseline Characteristics of a North American Pediatric Eye Disease Registry

Effect of Patching Versus Observation on Intermittent Exotropia-Specific Health-Related Quality of Life in Children and their Parents

Lessons learned from the Amblyopia Treatment Studies

Time Course and Predictors of Amblyopia Improvement with 2 Hours of Daily Patching

Evaluation of the Intermittent Exotropia Questionnaire (IXTQ) using Rasch Analysis

Progressive-Addition Lenses versus Single-Vision Lenses for Slowing Progression of Myopia in Children with High Accommodative Lag and Near Esophoria

Optical Treatment of Strabismic and Combined Strabismic-Anisometropic Amblyopia

Response to Amblyopia Therapy Depends on Child's Age

How Does One Define Success in Amblyopia Treatment?

Treatment of Severe Amblyopia With Atropine: Results From Two Randomized Clinical Trials

Defining Stability and Instability in Esotropia

Left Eye Predominance in Amblyopia

Prevalence of Astigmatism in Infants and Young Children: The Multi-Ethnic Pediatric Eye Disease Study

Treatment of Bilateral Refractive Amblyopia in Children 3-9 Years Old

Treatment of Amblyopia With Refractive Correction Alone

A New Symptom Survey and Quality of Life Questionnaire for Nasolacrimal Duct Obstruction

To View More...

You must be signed into an individual account to use this feature.